Alere to Develop Simple, Affordable Point-of-Care Nucleic Acid Test for Tuberculosis & Expand Manufacturing for POC HIV Viral Load Platform WALTHAM, Mass., March 1, 2013 /PRNewswire/ -- Alere Inc.

Each year, 9.6 million people become infected with tuberculosis; 1.5 million of them die. The rest silently carry the bacterium in a latent state, with the constant threat that it could become active ...

The $21.6 million grant will fund the development of a tuberculosis assay, which will be designed for use in both resource-constrained and well-resourced settings. It will also support the company’s ...

A simple blood test that accurately diagnoses active tuberculosis could save hundreds of thousands of lives each year, experts said today. The test makes it easier and cheaper to control the disease, ...

The number one killer of HIV patients in resource-limited areas, including parts of Africa and India, is tuberculosis (TB), underscoring the need for optimal treatments and effective strategies to ...